tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ACAD Stock Latest News

Acadia Pharmaceuticals Appoints Jonathan Poole to Board, Audit Committee
Company AnnouncementsAcadia Pharmaceuticals Appoints Jonathan Poole to Board, Audit Committee
10d ago
8K
ACAD
Acadia Pharmaceuticals price target raised to $34 from $31 at JPMorgan
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $34 from $31 at JPMorgan
11d ago
ACAD
Acadia Pharmaceuticals price target lowered to $29 from $31 at BofA
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $29 from $31 at BofA
12d ago
ACAD
Balancing EU Setback and Pipeline Optionality: Justifying a Hold on ACADIA
PremiumRatings
Balancing EU Setback and Pipeline Optionality: Justifying a Hold on ACADIA
12d ago
ACAD
ACADIA Pharmaceuticals Charts Growth Path After Record Year
PremiumCompany Announcements
ACADIA Pharmaceuticals Charts Growth Path After Record Year
13d ago
ACAD
Acadia Pharmaceuticals price target lowered to $33 from $36 at Citi
PremiumThe FlyAcadia Pharmaceuticals price target lowered to $33 from $36 at Citi
16d ago
ACAD
Acadia Pharmaceuticals price target raised to $37 from $35 at TD Cowen
Premium
The Fly
Acadia Pharmaceuticals price target raised to $37 from $35 at TD Cowen
17d ago
ACAD
Acadia Pharmaceuticals price target raised to $26 from $25 at Morgan Stanley
Premium
The Fly
Acadia Pharmaceuticals price target raised to $26 from $25 at Morgan Stanley
17d ago
ACAD
Acadia Pharmaceuticals price target lowered to $24 from $25 at Stifel
PremiumThe Fly
Acadia Pharmaceuticals price target lowered to $24 from $25 at Stifel
17d ago
ACAD
Acadia Pharmaceuticals price target raised to $35 from $34 at Citizens
PremiumThe Fly
Acadia Pharmaceuticals price target raised to $35 from $34 at Citizens
17d ago
ACAD
Balancing Daybue Momentum and Nuplazid Uncertainty: Justifying a Neutral Stance on ACADIA
PremiumRatings
Balancing Daybue Momentum and Nuplazid Uncertainty: Justifying a Neutral Stance on ACADIA
17d ago
ACAD
ACADIA Pharmaceuticals: Accelerating Commercial Momentum and Expanded Outlook Support Raised Price Target and Buy Rating
PremiumRatings
ACADIA Pharmaceuticals: Accelerating Commercial Momentum and Expanded Outlook Support Raised Price Target and Buy Rating
17d ago
ACAD
Balancing Robust Nuplazid Outlook and RADIANT Trial Uncertainty: Rationale for Maintaining a Hold on Acadia
PremiumRatingsBalancing Robust Nuplazid Outlook and RADIANT Trial Uncertainty: Rationale for Maintaining a Hold on Acadia
17d ago
ACAD
Acadia Pharmaceuticals reports Q4 EPS $1.60 vs 86c last year
Premium
The Fly
Acadia Pharmaceuticals reports Q4 EPS $1.60 vs 86c last year
17d ago
ACAD
Acadia Pharmaceuticals sees FY26 revenue $1.22B-$1.28B, consensus $1.2B
Premium
The Fly
Acadia Pharmaceuticals sees FY26 revenue $1.22B-$1.28B, consensus $1.2B
17d ago
ACAD
Acadia Pharmaceuticals initiated with an Outperform at Wolfe Research
PremiumThe Fly
Acadia Pharmaceuticals initiated with an Outperform at Wolfe Research
20d ago
ACAD
Acadia Pharmaceuticals upgraded to Outperform from Neutral at Mizuho
PremiumThe Fly
Acadia Pharmaceuticals upgraded to Outperform from Neutral at Mizuho
20d ago
ACAD
ACAD Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ACAD Upcoming Earnings Report: What to Expect?
20d ago
ACAD
ACADIA’s ACP-211 Trial Targets Difficult-to-Treat Depression: What Investors Should Watch
PremiumCompany Announcements
ACADIA’s ACP-211 Trial Targets Difficult-to-Treat Depression: What Investors Should Watch
1M ago
ACAD
Acadia Pharmaceuticals price target raised to $23 from $21 at Oppenheimer
PremiumThe FlyAcadia Pharmaceuticals price target raised to $23 from $21 at Oppenheimer
1M ago
ACAD
ACADIA Pharmaceuticals: U.S. Commercial Execution and Pipeline Optionality Drive Undervalued Buy Thesis Despite EU Trofinetide Delay
Premium
Ratings
ACADIA Pharmaceuticals: U.S. Commercial Execution and Pipeline Optionality Drive Undervalued Buy Thesis Despite EU Trofinetide Delay
1M ago
ACAD
Acadia Pharmaceuticals price target lowered to $31 from $35 at RBC Capital
Premium
The Fly
Acadia Pharmaceuticals price target lowered to $31 from $35 at RBC Capital
1M ago
ACAD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >